Dividend Hunting In Bear Country

One stock in the pharmaceutical sector has been calling to me lately like a siren song amid market turbulence. I’m talking about Bristol-Myers Squibb Co. (BMY), which has taken a beating in the March-April selloff but is dangling a forward estimated 5% dividend yield while generating a whopping 14% annual free cash flow — tops […]

My Favorite Passive/Aggressive Portfolio

What if you want to be a little more aggressive with your investment strategy, say twice as aggressive? What if markets don’t deliver any year-on-year change from here? Then you need a little more pizzazz in your portfolio, and some extra leverage to earn your crust of bread and secure your retirement. It turns out […]